FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 4103597 · Received September 19, 2014

Report

Report Number
2032227-2014-26457
Event Type
Malfunction
Date Received
September 19, 2014
Date of Event
August 20, 2014
Report Date
August 22, 2014
Manufacturer
MEDTRONIC MINIMED
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE INSULIN PUMP WAS UNABLE TO PRIME DURING PRIME TEST DUE TO FAULTY FORCE SENSOR RESISTOR. THE DEVICE PASSED THE DISPLACEMENT, REWIND, AND BASIC OCCLUSION TESTS. NO MOTOR ERROR ALARM NOTED AND THE MOTOR PASSED MOTOR TEST. THE DEVICE HAD CRACKED CASE AT DISPLAY WINDOW CORNER, RESERVOIR TUBE LIP, BROKEN BELT CLIP SLOT, AND MINOR SCRATCHED DISPLAY WINDOW.

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. THE DEVICE HAS BEEN RETURNED, BUT NOT YET EVALUATED. FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. THIS MDR RELATED TO THE (B)(4) MANUFACTURING SITE HAS BEEN ASSIGNED A MEDWATCH NUMBER FROM THE MEDTRONIC MINIMED (B)(4) SITE, PER VARIANCE 5.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CUSTOMER RECEIVED A MOTOR ERROR ALARM ON THE INSULIN PUMP DURING A BOLUS DELIVERY ATTEMPT. THE CUSTOMER'S BLOOD GLUCOSE WAS NOT RECALLED DURING TROUBLESHOOTING, THE CUSTOMER STATED THE INSULIN PUMP WAS NOT EXPOSED TO A STRONG MAGNETIC FIELD. THE CUSTOMER DOES NOT USE THE SENSOR FEATURE ON THE INSULIN PUMP. THE CUSTOMER STATED HE WAS ABLE TO REWIND THE INSULIN PUMP AND WAS ADVISED TO DISCONTINUE USE AND REVERT TO A BACK-UP PLAN. NOTHING FURTHER WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
582536 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC MINIMED MMT-723NAB

Patients

Seq Age Sex Outcome Treatment
1 44 YR